Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors-Reference-Cited by-同舟云学术

Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors

Published:2022-06 Issue: Volume:40 Page:46-53
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Gariscsak Peter J.^ORCID,Anson-Cartwright Lynn,Atenafu Eshetu G.,Jiang Di Maria,Chung Peter,Bedard Philippe,Warde Padraig,O'Malley Martin,Sweet Joan,Glicksman Rachel M.,Hamilton Robert J.^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort;Daugaard;J Clin Oncol,2014

2. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance;Kollmannsberger;J Clin Oncol,2015

3. The association between institution at orchiectomy and outcomes on active surveillance for clinical stage I germ cell tumours;Nayan;Can Urol Assoc J,2016

4. Guidelines on testicular cancer: 2015 update;Albers;Eur Urol,2015

5. Testicular cancer, version 2.2015;Motzer;J Natl Compr Cancer Netw,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS);European Urology Open Science;2024-10

2. Oncological treatments have limited effects on the fertility prognosis in testicular cancer: A systematic review and meta‐analysis;Andrology;2024-08-27

3. SEOM-GG clinical guidelines for the management of germ-cell testicular cancer (2023);Clinical and Translational Oncology;2024-07-03

4. Optimal imaging techniques across the spectrum of testicular cancer;Urologic Oncology: Seminars and Original Investigations;2024-07

5. Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations;JCO Oncology Practice;2023-11